Usui S, Yu L, Harmon J, Yu C A
Department of Biochemistry, Oklahoma State University, Stillwater 74078.
Arch Biochem Biophys. 1991 Aug 15;289(1):109-17. doi: 10.1016/0003-9861(91)90449-s.
A preparation containing the Mr 13,400 protein (subunit VI), phospholipid, and ubiquinone was isolated from bovine heart mitochondrial ubiquinol-cytochrome c reductase by a procedure involving Triton X-100 and urea solubilization, calcium phosphate-cellulose column chromatography at different pHs, acetone precipitation, and decanoyl-N-methylglucamide-sodium cholate extraction. The protein in this preparation corresponds to subunit VI of ubiquinol-cytochrome c reductase resolved in the sodium dodecyl sulfate-polyacrylamidce gel electrophoresis system of Schägger et al. (1987, FEBS Lett. 21, 161-168) and has the same amino acid sequence as that of the Mr 13,400 protein reported by Wakabayashi et al. (1985, J. Biol. Chem. 260, 337-343). The phospholipid and ubiquinone present in the preparation copurify with but are not intrinsic components of, the Mr 13,400 protein. This preparation has a potency and behavior identical to that of a free phospholipid preparation in restoring activity to delipidated ubiquinol-cytochrome c reductase. Antibodies against Mr 13,400 react only with Mr 13,400 protein and complexes which contain it. They do not inhibit intact, lipid-sufficient ubiquinol-cytochrome c reductase. However, when delipidated ubiquinol-cytochrome c reductase is incubated with antibodies prior to reconstitution with phospholipid, a 55% decrease in the restoration activity is observed, indicating that the catalytic site-related epitopes of the Mr 13,400 protein are buried in the phospholipid environment. Antibodies against Mr 13,400 cause an increase of apparent Km for ubiquinol-2 in ubiquinol-cytochrome c reductase. When mitoplasts or submitochondrial particles are exposed to a horseradish peroxidase conjugate of the Fab' fragment of anti-Mr 13,400 antibodies, peroxidase activity is found mainly in the submitochondrial particles preparation; little activity is detected in mitoplasts. This suggests that the Mr 13,400 protein is extruded toward the matrix side of the membrane.
通过一种涉及Triton X-100和尿素增溶、不同pH值下的磷酸钙-纤维素柱层析、丙酮沉淀以及癸酰-N-甲基葡糖酰胺-胆酸钠提取的方法,从牛心线粒体泛醇-细胞色素c还原酶中分离出一种含有相对分子质量为13,400的蛋白质(亚基VI)、磷脂和泛醌的制剂。该制剂中的蛋白质对应于Schägger等人(1987年,《欧洲生物化学学会联合会快报》21卷,161 - 168页)十二烷基硫酸钠-聚丙烯酰胺凝胶电泳系统中分离出的泛醇-细胞色素c还原酶的亚基VI,并且其氨基酸序列与Wakabayashi等人(1985年,《生物化学杂志》260卷,337 - 343页)报道的相对分子质量为13,400的蛋白质相同。制剂中存在的磷脂和泛醌与相对分子质量为13,400的蛋白质共纯化,但不是其固有成分。该制剂在恢复脱脂泛醇-细胞色素c还原酶活性方面具有与游离磷脂制剂相同的效力和行为。针对相对分子质量为13,400的蛋白质的抗体仅与相对分子质量为13,400的蛋白质及其包含它的复合物发生反应。它们不抑制完整的、脂质充足的泛醇-细胞色素c还原酶。然而,当脱脂泛醇-细胞色素c还原酶在用磷脂重构之前与抗体孵育时,观察到恢复活性下降了55%,这表明相对分子质量为13,400的蛋白质的催化位点相关表位被埋在磷脂环境中。针对相对分子质量为13,400的蛋白质的抗体导致泛醇-细胞色素c还原酶中泛醇-2的表观米氏常数增加。当线粒体质或亚线粒体颗粒暴露于抗相对分子质量为13,400的抗体的Fab'片段的辣根过氧化物酶缀合物时,过氧化物酶活性主要在亚线粒体颗粒制剂中发现;在线粒体质中检测到的活性很少。这表明相对分子质量为13,400的蛋白质被挤出到膜的基质侧。